title: Temporal effects of exogenous oocyte-secreted factors on bovine oocyte developmental competence during IVM.
abstract: We investigated whether paracrine signalling between the bovine oocyte and cumulus cells is altered during the course of in vitro maturation (IVM). Bovine COCs were cocultured with denuded oocytes or treated with specific oocyte-secreted factors, namely recombinant bone morphogenetic protein (BMP)-15 or growth differentiation factor (GDF)-9, beginning from 0 or 9h IVM. To generate a 9-h denuded oocyte (DO) group, COCs were cultured intact for the first 9h of IVM and then denuded. Coculturing intact COCs with DOs denuded immediately after collection or following 9h of maturation did not affect cleavage rate, but improved blastocyst yield (P<0.05) on Day 8 (51 and 61%, respectively; P<0.05) and cell number compared with COCs cultured alone (41%). Significantly, we observed higher levels of endogenous GDF-9 and BMP-15 protein in oocytes of COCs matured for 9h compared with no incubation. The addition of 175 ng mL(-1) GDF-9 or 10%v/v BMP-15 from partially purified transfected 293H cell supernatant for 24h IVM significantly enhanced development to the blastocyst stage from 40% (control) to 51 and 47%, respectively (P<0.05). However, treatment of COCs with GDF-9 or BMP-15 between 9 and 24h of IVM did not increase blastocyst yield. These results provide evidence of quantitative and possibly qualitative temporal changes in oocyte paracrine factor production during IVM.
authors.affiliation: Robinson Institute, Research Centre for Reproductive Health, School of Paediatrics and Reproductive Health, The University of Adelaide, Adelaide, SA 5005, Australia.
authors.forename: Tamer S
authors.initials: TS
authors.lastname: Hussein
authors.forename: Melanie L
authors.initials: ML
authors.lastname: Sutton-McDowall
authors.forename: Robert B
authors.initials: RB
authors.lastname: Gilchrist
authors.forename: Jeremy G
authors.initials: JG
authors.lastname: Thompson
mesh_terms: D000818:Animals; D055430:Bone Morphogenetic Protein 15 / Q000378:metabolism / Q000494:pharmacology; D002417:Cattle; D002478:Cells, Cultured; D018920:Coculture Techniques; D017077:Culture Media, Conditioned / Q000494:pharmacology*; D054885:Cumulus Cells / Q000187:drug effects / Q000502:physiology; D004353:Drug Evaluation, Preclinical; D005260:Female; D055429:Growth Differentiation Factor 9 / Q000378:metabolism / Q000494:pharmacology; D006801:Humans; D008954:Models, Biological; D009865:Oocytes / Q000187:drug effects* / Q000378:metabolism* / Q000502:physiology*; D009866:Oogenesis / Q000187:drug effects* / Q000502:physiology; D013997:Time Factors
chemical_list: D055430:Bone Morphogenetic Protein 15; D017077:Culture Media, Conditioned; D055429:Growth Differentiation Factor 9